UK mothers back cervical cancer vaccine for kids

	Tweet

Three-quarters of mothers in Britain want their young daughters to be vaccinated against a sexually transmitted virus that causes most cases of cervical cancer, a poll released on Wednesday showed.

Most of the women questioned in the survey by the charity Cancer Research UK think the best age to be immunised against the human papillomavirus (HPV) would be between 10-14 years old. 

Although many of the mothers were concerned about possible side effects, only 12 percent said they were worried that having the jab would make their daughters more likely to become sexually active.

“The results are encouraging in that they show most parents approve of vaccinating girls at the age of 12,” Professor Jane Wardle, lead author of the survey, said in a statement.

“This suggests that a school-based programme of vaccination is likely to find approval among parents,” she added.

HPV is linked to 70 percent of cervical cancer cases. It is a common infection that usually lasts only for a short time and produces no symptoms.

But in some women it can progress to cervical cancer, one of the commonest female cancers.

Each year 470,000 women around the world are diagnosed with the disease and 230,000, mostly in the developing world, die, according to the International Agency for Research on Cancer in Lyon, France.

Two leading drugs companies have developed experimental cervical cancer vaccines.

GlaxoSmithKline Plc said earlier this month it would launch a head-to-head clinical trial of its Cervarix vaccine against Merck & Co’s Gardasil, which is already on the market.

Both vaccines have been shown to be highly effective against HPV in clinical trials. 

RELATED STORIES:
CDC recommends human papillomavirus virus vaccination   US FDA approves Hycamtin for cervical cancer   HPV screen-and treat-intervention effective in cervical cancer prevention   Fewer than 3 doses of cervical cancer vaccine effective   Higher rates of cervical cancer amongst immigrants   HPV shot too costly for the Netherlands: study   FDA approval of Gardasil to prevent cervical cancer   Cervical disease sufferers could benefit from HPV vaccine   Glaxo HPV vaccine shows promise for women 26-55   Health groups issue proposed cervical cancer screening guidelines   HIV drug stops cervical cancer in laboratory test   Cervical cancer screening rates low in poor areas   HPV Clearance Tied to Cervical Cancer Disparity   Obese women in Canada are less likely to be screened for cervical cancer   Common virus kills cancer   Cervical cancer vaccine can protect men from HPV   Doctors say HPV vaccine should be given to everyone   Staging of cervical cancer complicating pregnancy   Study determines costs of breast and cervical cancer detection among low-income women   Cervical cancer vaccine tipped for nine year olds   Weakened RNA Interference Reduces Survival in Ovarian Cancer   “Screen and treat” cervical cancer programs effective in poorly resourced areas

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]